Maria J. Juachon
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Intravaginal Delivery of Oxybutynin: An Alternative Administration Route to Improve its Pharmacokinetic and Pharmacodynamic Effects.
Journal: European urology open science
Published: July 09, 2026
Pharmacokinetics and pharmacodynamics of orally administered S-ketamine in healthy participants.
Journal: Journal of psychopharmacology (Oxford, England)
Published: June 25, 2026
Introducing personalized patient care in overactive bladder management using the MedRing OAB system for intravaginal oxybutynin administration.
Journal: Drug delivery
Published: January 24, 2026
Real-World Glucometric Outcomes of the MiniMed 780G Advanced Hybrid Closed-Loop System in Users with Type 1 Diabetes in Spain.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: January 19, 2026
Transcranial Magnetic Stimulation as a Translational Biomarker in Early-Phase Anti-Seizure Medication Development: A Randomized, Double-Blind, Placebo-Controlled Study in Generalized Epilepsy.
Journal: Clinical pharmacology and therapeutics
Published: January 09, 2026
Intravenous Lipopolysaccharide Challenge in Healthy Participants Reveals Pharmacodynamic Markers in Blood and Bone Marrow for Early-Phase Oncology Drug Development.
Journal: Clinical pharmacology and therapeutics
Published: December 20, 2025
Sustained pharmacodynamic effects of S-ketamine on cortical excitability and resting-state brain activity: A randomized, placebo-controlled trial.
Journal: British journal of clinical pharmacology
Published: October 17, 2025
A novel psychedelic 5-HT2A receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer.
Journal: Journal of psychopharmacology (Oxford, England)
Published: October 16, 2025
Application of a Nociceptive Test Battery to Assess Potential Synergy between Two Analgesics in Healthy Subjects.
Journal: ACS pharmacology & translational science
Published: November 28, 2024
CB1 Receptor Antagonist Selonabant (ANEB-001) Blocks Acute THC Effects in Healthy Volunteers: A Phase II Randomized Controlled Trial.
Journal: Clinical pharmacology and therapeutics
Published: August 16, 2024
The interactive walkway provides fit-for-purpose fall-risk biomarkers in the elderly: Comparison of zolpidem and suvorexant.
Journal: Clinical and translational science
Published: March 21, 2024
Immune responsiveness in stable kidney transplantation patients: Complete inhibition of T-cell proliferation but residual T-cell activity during maintenance immunosuppressive treatment.
Journal: Clinical and translational science
Published: March 05, 2024
Last Updated: 09/26/2026